Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty
Trial end date:
SummaryThe purpose of this study is to compare the efficacy of two prophylactic agent(aspirin 300mg/day and rivaroxaban 10mg/day) for venous thromboembolism after total knee arthroplasty.
Accepts Healthy Volunteers?No
Hanyang University Seoul Hospital
- all patients undergone primary total knee arthroplasty
- renal insufficiency, contrast allergy, simultaneous bilateral TKA, hemorrhagic
disorder, sever liver disease